SYRAOTCServices-Employment AgenciesFiscal year ends December 31
Syra Health Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$0.83−0.03 (-3.98%)
Close on Oct 19, 2026
- Market cap
- $11.19M
- P/E (TTM)
- 82.6
- Dividend yield
- –
Syra Health statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Services-Employment Agencies companies for comparison
Valuation
| Measure | Syra Health | Industry median |
|---|---|---|
| Market Cap | $11.43M | $283.76M |
| Enterprise Value | $9.30M | $296.20M |
| PE Ratio | 82.58 | 25.42 |
| PS Ratio | 1.41 | 2.36 |
| PB Ratio | 4.34 | 2.67 |
| P/TBV Ratio | 4.34 | 4.90 |
| P/OCF Ratio | 104.19 | 13.05 |
Enterprise value
| Measure | Syra Health | Industry median |
|---|---|---|
| EV / Sales | 1.15 | 2.14 |
| EV / EBITDA | 124.52 | 16.16 |
| EV / EBIT | 124.52 | 21.55 |
Income (trailing twelve months)
| Measure | Syra Health | Industry median |
|---|---|---|
| Revenue | $8.09M | $289.17M |
| Gross Profit | $3.18M | $161.98M |
| Operating Income | $74.72K | -$613.24K |
| Net Income | $130.75K | -$301.07K |
| EBITDA | $74.72K | -$156.35K |
| EPS (Diluted) | $0.01 | $0.00 |
Margins
| Measure | Syra Health | Industry median |
|---|---|---|
| Gross Margin | 39.3% | 55.8% |
| Operating Margin | 0.92% | -1.81% |
| Profit Margin | 1.62% | -1.80% |
| EBITDA Margin | 0.92% | 0.60% |
Returns
| Measure | Syra Health | Industry median |
|---|---|---|
| Return on Equity (ROE) | 5.18% | 0.83% |
| Return on Assets (ROA) | 3.58% | -2.82% |
| Return on Invested Capital (ROIC) | 19.1% | -0.05% |
| Return on Capital Employed (ROCE) | 2.84% | -0.44% |
Growth
| Measure | Syra Health | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 0.32% | 9.72% |
| Revenue Growth (3Y CAGR) | 8.75% | 7.66% |
Balance sheet
| Measure | Syra Health | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $2.12M | $43.42M |
| Net Cash (Debt) | $2.12M | $2.04M |
| Net Cash Per Share | $0.15 | $0.15 |
| Equity (Book Value) | $2.63M | $52.29M |
| Book Value Per Share | $0.19 | $1.93 |
| Tangible Book Value | $2.63M | $3.06M |
| Working Capital | $2.55M | $15.22M |
Financial position
| Measure | Syra Health | Industry median |
|---|---|---|
| Current Ratio | 3.13 | 1.40 |
| Quick Ratio | 3.00 | 0.94 |
| Interest Coverage | 6.88 | -0.66 |
Cash flow (trailing twelve months)
| Measure | Syra Health | Industry median |
|---|---|---|
| Operating Cash Flow | $109.68K | $8.52M |
Efficiency
| Measure | Syra Health | Industry median |
|---|---|---|
| Asset Turnover | 2.22 | 0.64 |
| Revenue Per Employee | $212.89K | $392.99K |
| Profits Per Employee | $3.44K | -$4.47K |
| Employee Count | 38 | 531 |
Dividends and yields
| Measure | Syra Health | Industry median |
|---|---|---|
| Earnings Yield | 1.14% | -0.92% |
Shares
| Measure | Syra Health | Industry median |
|---|---|---|
| Shares Outstanding | 13,839,200 | 58,826,100 |
| Shares Change (YoY) | 23.6% | 2.21% |
| Float | 12,843,000 | 52,938,050 |
| Shares Held by Insiders | 7.20% | 13.2% |
Scores
| Measure | Syra Health | Industry median |
|---|---|---|
| Graham Number | $0.21 | $15.96 |
| Graham Upside | -74.9% | -55.7% |
| Altman Z-Score | 5.33 | 1.50 |
| Piotroski F-Score | 5 | 5 |
Calculated by StockData from Syra Health's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.